Literature DB >> 11477662

Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.

S Ward1, B Harding, P Wilkins, W Harkness, R Hayward, J L Darling, D G Thomas, T Warr.   

Abstract

Ependymomas are the third most common brain tumour in the paediatric population. Although cytogenetic and molecular analyses have pinpointed deletions of chromosomes 6q, 17, and 22 in a subset of tumours, definitive patterns of genetic aberrations have not been determined. In the present study, we analysed 40 ependymomas from paediatric patients for genomic loss or gain using comparative genomic hybridisation (CGH). Eighteen of the tumours (45%) had no detectable regions of imbalance. In the remaining cases, the most common copy number aberrations were loss of 22 (25% of tumours) and gain of 1q (20%). Three regions of high copy number amplification were noted at 1q24-31 (three cases), 8q21-23 (two cases), and 9p (one case). Although there was no association with the loss or gain of any chromosome arm or with benign versus anaplastic histologic characteristics, the incidence of gain of 7q and 9p and loss of 17 and 22 was significantly higher in recurrent versus primary tumours. This study has identified a number of chromosomal regions that may contain candidate genes involved in the development of different subgroups of ependymoma. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11477662     DOI: 10.1002/gcc.1167

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  29 in total

1.  Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.

Authors:  Sara Dyer; Emma Prebble; Val Davison; Paul Davies; Pramila Ramani; David Ellison; Richard Grundy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.

Authors:  Chang-Hyun Lee; Chun Kee Chung; Chi Heon Kim
Journal:  Eur Spine J       Date:  2016-09-16       Impact factor: 3.134

Review 3.  Molecular analysis of pediatric brain tumors.

Authors:  Jaclyn A Biegel; Ian F Pollack
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

4.  Aberrant CpG island methylation of multiple genes in ependymal tumors.

Authors:  M Eva Alonso; M Josefa Bello; Pilar Gonzalez-Gomez; Dolores Arjona; Jose M de Campos; Manuel Gutierrez; Juan A Rey
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 5.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

Review 6.  Survival following treatment for intracranial ependymoma: a review.

Authors:  G Tamburrini; M D'Ercole; B L Pettorini; M Caldarelli; L Massimi; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-04-22       Impact factor: 1.475

7.  Molecular characterization of the pediatric preclinical testing panel.

Authors:  Geoffrey Neale; Xiaoping Su; Christopher L Morton; Doris Phelps; Richard Gorlick; Richard B Lock; C Patrick Reynolds; John M Maris; Henry S Friedman; Jeffrey Dome; Joseph Khoury; Timothy J Triche; Robert C Seeger; Richard Gilbertson; Javed Khan; Malcolm A Smith; Peter J Houghton
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

Review 8.  Molecular profiling of pediatric brain tumors: insight into biology and treatment.

Authors:  Robert Johnson; Karen D Wright; Richard J Gilbertson
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

Review 9.  The genetic and epigenetic basis of ependymoma.

Authors:  Stephen C Mack; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2009-06-18       Impact factor: 1.475

10.  Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.

Authors:  Audrey Rousseau; Ahmed Idbaih; François Ducray; Emmanuelle Crinière; Michèle Fèvre-Montange; Anne Jouvet; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2009-10-29       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.